Getinge 2022 Annual Report

Getinge 2022 Annual Report Introduction Strategy Corporate Governance Annual Report Sustainability Report Other information Contents External trends impacting Getinge's business Getinge operates globally, and although the conditions between markets may differ, many of the influences from around the world are the same. GROWING POPULATION & LONGER LIFE EXPECTANCY The need for healthcare is increasing in all parts of the world as the global population is growing and people are living longer. TEMPORARY BUSINESS CHALLENGES The lockdowns in China as a result of the COVID-19 pandemic and the war in Ukraine have impacted global supply chains. This has resulted in increased inflation, component shortages and comprehensive logistics challenges. Many people that work in healthcare have also left the profession in con- junction with the pandemic, making it difficult to reduce wait times. INNOVATION AND COLLABORATION Producing new, value-adding innovations and outcome-based remu- neration models increasingly requires digitalization and global collaboration between several parties. CUSTOMIZED DRUGS Biopharma has developed rapidly in recent years based on the industry's ability to produce customized drugs. Getinge's response Getinge supports its customers in creating sustainable and efficient healthcare systems in which therapies and equipment can add value in the form of improved quality and lower cost, without compromising safety. Getinge's response Getinge works actively together with its suppliers to mitigate limitations in the supply chain and to help reduce cost increases than what would otherwise be the case. Getinge also focuses on spreading knowledge of the products and services that increase productivity in healthcare with the aim of mitigating the effect of staff shortages. Getinge's response In addition to proprietary product development, Getinge is part of strategic partnerships to drive digital ecosystems that offer the prerequisites for future healthcare. The company also works with financial solutions in its conviction that all people and societies should have access to the best possible healthcare. Getinge's response Getinge's solutions prevent contamina- tion in biopharmaceutical production and help drug manufacturers to meet the industry's unique challenges, be it complying with strict guidelines, maintaining high performance, maxi- mizing productivity or optimizing production processes. 10

View entire presentation